Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G V Doern

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Diagnostic Microbiology and Infectious Disease|May 8, 1998
Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study GroupR N Jones, M A Pfaller, G V Doern, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 14, 2006
Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control studyS E Beekmann, D J Diekema, K P Heilmann, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 1, 1993
Comparison of four methods in the diagnosis of Clostridium difficile diseaseA R Mattia, G V Doern, J Clark, et al.
Diagnostic Microbiology and Infectious Disease|May 26, 1999
Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America)G V Doern, R N Jones, M A Pfaller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 1999
Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995V D Shortridge, G V Doern, A B Brueggemann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2001
Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999D J Hoban, G V Doern, A C Fluit, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisA B Brueggemann, G V Doern, H K Huynh, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1990
Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United StatesJ H Jorgensen, G V Doern, L A Maher, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 1998
In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella sppM A Croco, D J Biedenbach, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|February 6, 1999
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance ProgramG V Doern, M A Pfaller, M E Erwin, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Diagnostic Microbiology and Infectious Disease|May 8, 1998
Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study GroupR N Jones, M A Pfaller, G V Doern, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 14, 2006
Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control studyS E Beekmann, D J Diekema, K P Heilmann, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 1, 1993
Comparison of four methods in the diagnosis of Clostridium difficile diseaseA R Mattia, G V Doern, J Clark, et al.
Diagnostic Microbiology and Infectious Disease|May 26, 1999
Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America)G V Doern, R N Jones, M A Pfaller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 1999
Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995V D Shortridge, G V Doern, A B Brueggemann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2001
Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999D J Hoban, G V Doern, A C Fluit, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisA B Brueggemann, G V Doern, H K Huynh, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1990
Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United StatesJ H Jorgensen, G V Doern, L A Maher, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 1998
In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella sppM A Croco, D J Biedenbach, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|February 6, 1999
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance ProgramG V Doern, M A Pfaller, M E Erwin, et al.
Pageof 17